India’s Ozone Targets Five Half-Price Generics For Indian Market
This article was originally published in PharmAsia News
Executive Summary
Ozone Group says it plans to bring to India's market in July five drugs it will price at half the cost of what already is available. Ozone is one of a group of Indian pharmas seeking to counter an influx of questionable branded drugs into India by offering cheaper generics. Ozone's plans are focused on five drugs - an antibiotic and drugs to treat diarrhea, ulcers, pyretic and a painkiller. The firm's chairman and managing director. S.C. Sehgal, said the intent is to make available cheaper drugs with no sacrifice of quality, so he does not expect to garner major revenues from the drugs. (Click here for more